News & Updates
Showing Gastroenterology articles
Showing
Show Multimedia Only

Osemitamab plus CAPOX proven safe, prolongs survival in advanced G/GEJ cancer
15 Nov 2023
byStephen Padilla
First-line treatment with TST001 (osemitamab) in combination with capecitabine and oxaliplatin (CAPOX) is safe and well tolerated in patients with advanced gastric/gastroesophageal junction (G/GEJ) cancer, according to a study presented at ESMO 2023.
15 Nov 2023

Does intermittent fasting reduce acid exposure in GERD patients?
06 Nov 2023
Patients with suspected gastroesophageal reflux disease (GERD) may find it difficult to follow a time-restricted eating, reports a study. Additionally, there is weak evidence to suggest that intermittent fasting helps ease acid exposure.
06 Nov 2023

Histologic inflammation of IBD a risk factor for serious infections
03 Nov 2023
Among individuals with inflammatory bowel disease (IBD), histologic inflammation appears to contribute to an increased risk of serious infections such as sepsis, according to a study, suggesting that achieving remission may reduce infections in IBD.
03 Nov 2023






